Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...

Phase 3 trial results show remibrutinib significantly improves complete response rates in patients with 3 types of chronic inducible urticaria.

With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...

Following a warning by a UK regulator about a small risk of severe acute pancreatitis with weight loss jabs, Medical News Today spoke to 3 experts about who is most at risk and whether the benefits ...

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

GLP-1 drugs aid in weight loss and manage diabetes, expanding treatment for obesity and other conditions. Invest in GLP-1 via ETFs like Roundhill GLP-1 & Weight Loss ETF for a less risky strategy. Eli ...